|
Stage IIIB Anal Cancer
Current Clinical Trials
The presence of inguinal nodes that are involved with metastatic disease
(unilateral or bilateral) is a poor prognostic sign, though cure of this
stage of disease is possible. Because of the poor prognosis associated with
this stage, patients should be included in clinical trials whenever possible.
Standard treatment options:
- Radiation therapy plus chemotherapy (as described for stage II) with surgical
resection of residual disease at the primary site (local resection or
abdominoperineal resection) and unilateral or bilateral superficial and deep
inguinal node dissection for residual or recurrent tumor.
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage IIIB anal cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
Back to Top
< Previous Section | Next Section > |
